¡Ya estamos en ! Descubre más

Cronos Group

CRON

Capitalización de mercado USD 1183 M

3.21 USD

+0.01

0.31%

Al cierre Actualizado 16 oct, 4:00 p.m. EDT

Antes de la apertura del mercado

Después del cierre del mercado

3.21

0.00

0%

1 día

0.31%

5 días

-0.31%

1 mes

-2.43%

3 meses

16.73%

6 meses

19.78%

En lo que va del año

18.89%

1 año

29.44%

5 años

-40.11%

10 años

-57.87%

Acerca de: Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.

Empleados: 610

Atención médica Fabricantes de medicamentos especializados y genéricos

Noticias

Positivo

Neutral

Negativo

Sentimiento 3 meses

Positivo 37.5%

Neutral 54.2%

Negativo 8.3%

Cronos Completes Acquisition of CanAdelaar, Europe's Largest Adult-Use Cannabis Company

Cronos acquires CanAdelaar for a base purchase price of €57.5 million plus cash earnout of 0.5x Normalized EBITDA 1 in 2026 and 2027

Cronos Completes Acquisition of CanAdelaar, Europe's Largest Adult-Use Cannabis Company

Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season

TORONTO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that for the third consecutive year it is bringing back its popular limited-edition Caramel Green Apple flavor to its best-selling lineup of SOURZ by Spinach® edibles. For the first time, this seasonal flavor will launch exclusively in the SOURZ by Spinach® Fully Blasted 10-pack, the #1 edible multipack in Canada1.

Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season

Zacks Investment Research

CRON Stock Rises 17% in Three Months: Time to Buy the Dip or Cash Out?

Cronos Group stock climbs 17% in three months on strong revenue growth and margin gains, but rising competition and regulatory risks raise questions about its upside.

CRON Stock Rises 17% in Three Months: Time to Buy the Dip or Cash Out?

Cronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026

TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 third quarter earnings conference call on Thursday, November 5, 2026, at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

Cronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026

Cronos Group Inc. (CRON:CA) Analyst/Investor Day Transcript

Cronos Group Inc. (CRON:CA) Analyst/Investor Day Transcript

Cronos Group Inc. (CRON:CA) Analyst/Investor Day Transcript

Cronos Group Investor Day Highlights Cannabis Growth, Cash Flow and Global Ambitions

Cronos Group NASDAQ: CRON used its first Investor Day to outline its cultivation, genetics, brand and financial strategy, emphasizing its purpose-built greenhouse partnership with Mucci Farms, continued international expansion and a focus on cash flow generation.

Cronos Group Investor Day Highlights Cannabis Growth, Cash Flow and Global Ambitions

Cronos Hosts 2026 Investor Day

TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, is hosting its first Investor Day today, September 24, 2026, at its Cronos Growing Company Inc. Kingsville location.

Cronos Hosts 2026 Investor Day

Cronos: Invest In Cannabis With 50% Net Cash And GAAP Profitability

Cronos Group Inc. is upgraded to a Buy, driven by a best-in-class balance sheet and improved profitability. CRON boasts $827 million in cash, no debt, and strong international expansion, with adjusted gross margins reaching 46%. Profitability is supported by disciplined cost management and positive GAAP operating profit, distinguishing CRON from Canadian peers.

Cronos: Invest In Cannabis With 50% Net Cash And GAAP Profitability

Cronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, Ontario

Registration is now open for Cronos' first Investor Day, which will be hosted by the Cronos Leadership Team, on September 24, 2026 Registration is now open for Cronos' first Investor Day, which will be hosted by the Cronos Leadership Team, on September 24, 2026

Cronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, Ontario

Zacks Investment Research

Are Medical Stocks Lagging Cronos Group (CRON) This Year?

Here is how Cronos Group (CRON) and Curaleaf Holdings, Inc. (CURLF) have performed compared to their sector so far this year.

Are Medical Stocks Lagging Cronos Group (CRON) This Year?

Ver rankings de noticias

Gráficos de precios implementados con Lightweight Charts™